Comparative Results Of Shockwave Lithotripsy For Renal Calculi In Upper, Middle, And Lower Calices
Main Category: Urology / NephrologyArticle Date: 30 Dec 2007 - 1:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
4 (1 votes) |
UroToday.com- Using a Dornier MPL 9000, the authors provide a very thorough evaluation of treatments among 118 patients with solitary calyceal stones. Stone free was defined as < 3 mm on an intravenous urogram at 3 months. There is not much new here but it reinforces earlier works with the following observations:
a. Lower calyceal stones clear poorer than middle or upper calyceal calculi: 83%, 83%, and 68%. Of particular importance is that while these numbers look "good" at first glance, the efficiency quotients (i.e. % of stones requiring a single treatment without the attendant need for either retreatment or an auxiliary procedure) tell another story: 50%, 45%, and 33% respectively.
b. While calculi up to 2 cm can be treated, the success rate is less than for stones in the 1 cm or less range: 91% vs. 66% with an attendant increase in the mean number of treatment sessions from 1.9 to 2.4 (i.e. read: diminishing returns).
c. In this study, lower pole infundibular length and width were statistically significantly related to treatment success. However, this remains an ongoing controversial point of diminishing relevance given the demise of intravenous urography in the United States.
In sum, shock wave lithotripsy in 2007, in my opinion, likely is best reserved for those calculi up to 1 cm in size, with those stones larger than 2 cm being relegated to percutaneous procedures. For the stones in between 1-2 cm other factors such as location, density on CT scan, and the skin to stone distance should be considered in the decision making process for shock wave lithotripsy vs. ureteroscopy vs. percutaneous stone removal.
Turna B, Ekren F, Nazli O, Akbay K, Altay B, Ozyurt C, Cikill N
J Endourol. 21(9):951-956, September 2007
doi:10.1089/end.2007.0275.
Reported by UroToday.com Contributing Editor Ralph V. Clayman, M.D
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
----------------------------
Copyright © 2007 - UroToday
Reproduced for Medical News Today with permission of UroToday.
----------------------------
Visit our urology / nephrology section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/92783.php>
APA
http://www.medicalnewstoday.com/releases/92783.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




